مرکز منطقه ای اطلاع رساني علوم و فناوري - Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation

Title of article :

Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation

Author/Authors :

Ameri, Hossein USC Roski Eye Institute - Keck School of Medicine - University of Southern California, USA

Pages :

From page :

To page :

Abstract :

Keywords :

Editorial

Journal title :

Journal of Current Ophthalmology

DOI :

Serial Year :

2018

Journal title :

Journal of Current Ophthalmology

Record number :

2444808

Link To Document :